Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.

Kircheis G, Lüth S.

Drugs. 2019 Feb;79(Suppl 1):23-29. doi: 10.1007/s40265-018-1023-2. Review.

PMID:
30706424
2.

Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Butterworth RF, Kircheis G, Hilger N, McPhail MJW.

J Clin Exp Hepatol. 2018 Sep;8(3):301-313. doi: 10.1016/j.jceh.2018.05.004. Epub 2018 May 22.

PMID:
30302048
3.

Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients.

Baumgarten TJ, Neugebauer J, Oeltzschner G, Füllenbach ND, Kircheis G, Häussinger D, Lange J, Wittsack HJ, Butz M, Schnitzler A.

Neuroimage Clin. 2018 Aug 9;20:347-356. doi: 10.1016/j.nicl.2018.08.013. eCollection 2018.

4.

Ammonia-weighted imaging by chemical exchange saturation transfer MRI at 3 T.

Zöllner HJ, Butz M, Kircheis G, Klinker S, Häussinger D, Schmitt B, Schnitzler A, Wittsack HJ.

NMR Biomed. 2018 Sep;31(9):e3947. doi: 10.1002/nbm.3947. Epub 2018 Jul 5.

PMID:
29975436
5.

TNFα induced up-regulation of Na+,K+,2Cl- cotransporter NKCC1 in hepatic ammonia clearance and cerebral ammonia toxicity.

Pozdeev VI, Lang E, Görg B, Bidmon HJ, Shinde PV, Kircheis G, Herebian D, Pfeffer K, Lang F, Häussinger D, Lang KS, Lang PA.

Sci Rep. 2017 Aug 11;7(1):7938. doi: 10.1038/s41598-017-07640-8.

6.

Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.

Kummer S, Klee D, Kircheis G, Friedt M, Schaper J, Häussinger D, Mayatepek E, Meissner T.

Eur J Pediatr. 2017 Apr;176(4):529-536. doi: 10.1007/s00431-017-2876-1. Epub 2017 Feb 17.

PMID:
28213828
7.
8.

Ultrasonography of gallbladder abnormalities due to schistosomiasis.

Richter J, Azoulay D, Dong Y, Holtfreter MC, Akpata R, Calderaro J, El-Scheich T, Breuer M, Neumayr A, Hatz C, Kircheis G, Botelho MC, Dietrich CF.

Parasitol Res. 2016 Aug;115(8):2917-24. doi: 10.1007/s00436-016-5116-0. Epub 2016 May 12. Review.

PMID:
27169865
9.

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.

Shawcross DL, Dunk AA, Jalan R, Kircheis G, de Knegt RJ, Laleman W, Ramage JK, Wedemeyer H, Morgan IE; New Insights Steering Committee.

Eur J Gastroenterol Hepatol. 2016 Feb;28(2):146-52. doi: 10.1097/MEG.0000000000000529. Review.

10.

Qualifying and quantifying minimal hepatic encephalopathy.

Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K.

Metab Brain Dis. 2016 Dec;31(6):1217-1229. Epub 2015 Sep 28. Review.

PMID:
26412229
11.

Evaluation of Acoustic Radiation Force Impulse Imaging (ARFI) for the Determination of Liver Stiffness Using Transient Elastography as a Reference in Children.

Sagir A, Ney D, Oh J, Pandey S, Kircheis G, Mayatepek E, Häussinger D.

Ultrasound Int Open. 2015 Jul;1(1):E2-7. doi: 10.1055/s-0035-1554659.

12.

Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt.

Richter J, Bode JG, Blondin D, Kircheis G, Kubitz R, Holtfreter MC, Müller-Stöver I, Breuer M, Hüttig F, Antoch G, Häussinger D.

Lancet Infect Dis. 2015 Jun;15(6):731-7. doi: 10.1016/S1473-3099(15)70009-5. Epub 2015 Mar 11. Review.

PMID:
25769268
13.

Reply: To PMID 24365582.

Kircheis G, Hilger N, Häussinger D.

Gastroenterology. 2015 Mar;148(3):665-6. doi: 10.1053/j.gastro.2015.01.035. Epub 2015 Feb 3. No abstract available.

PMID:
25659764
14.

Patients with manifest hepatic encephalopathy can reveal impaired thermal perception.

Brenner M, Butz M, May ES, Kahlbrock N, Kircheis G, Häussinger D, Schnitzler A.

Acta Neurol Scand. 2015 Sep;132(3):156-63. doi: 10.1111/ane.12376. Epub 2015 Jan 28.

PMID:
25630844
15.

Hepatic encephalopathy is associated with slowed and delayed stimulus-associated somatosensory alpha activity.

May ES, Butz M, Kahlbrock N, Brenner M, Hoogenboom N, Kircheis G, Häussinger D, Schnitzler A.

Clin Neurophysiol. 2014 Dec;125(12):2427-35. doi: 10.1016/j.clinph.2014.03.018. Epub 2014 Mar 26.

PMID:
24747056
16.

Cortical activation associated with asterixis in manifest hepatic encephalopathy.

Butz M, Timmermann L, Gross J, Pollok B, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A.

Acta Neurol Scand. 2014 Oct;130(4):260-7. doi: 10.1111/ane.12217. Epub 2013 Dec 24.

PMID:
24372275
17.

Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.

Kircheis G, Hilger N, Häussinger D.

Gastroenterology. 2014 Apr;146(4):961-9. doi: 10.1053/j.gastro.2013.12.026. Epub 2013 Dec 21.

PMID:
24365582
18.

Correct determination of critical flicker frequency is mandatory when comparisons to other tests are made.

Kircheis G, Hilger N, Häussinger D.

Gut. 2014 Apr;63(4):701-2. doi: 10.1136/gutjnl-2013-305444. Epub 2013 Jul 11. No abstract available.

PMID:
23846484
19.

Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension.

Klasen J, Lanzman RS, Wittsack HJ, Kircheis G, Schek J, Quentin M, Antoch G, Häussinger D, Blondin D.

Magn Reson Imaging. 2013 Sep;31(7):1092-6. doi: 10.1016/j.mri.2013.01.003. Epub 2013 Jun 2.

PMID:
23731536
20.

[Hepatic encephalopathy].

Kircheis G, Häussinger D.

Dtsch Med Wochenschr. 2012 Aug;137(31-32):1582-5. doi: 10.1055/s-0032-1305170. Epub 2012 Jul 12. Review. German. No abstract available.

PMID:
22791574
21.

Evaluation of acoustic radiation force impulse imaging for determination of liver stiffness using transient elastography as a reference.

Kircheis G, Sagir A, Vogt C, Vom Dahl S, Kubitz R, Häussinger D.

World J Gastroenterol. 2012 Mar 14;18(10):1077-84. doi: 10.3748/wjg.v18.i10.1077.

22.

Lowered frequency and impaired modulation of gamma band oscillations in a bimodal attention task are associated with reduced critical flicker frequency.

Kahlbrock N, Butz M, May ES, Brenner M, Kircheis G, Häussinger D, Schnitzler A.

Neuroimage. 2012 May 15;61(1):216-27. doi: 10.1016/j.neuroimage.2012.02.063. Epub 2012 Mar 1.

PMID:
22405731
23.

Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.

Kubitz R, Bode J, Erhardt A, Graf D, Kircheis G, Müller-Stöver I, Reinehr R, Reuter S, Richter J, Sagir A, Schmitt M, Donner M.

Z Gastroenterol. 2011 Jun;49(6):728-36. doi: 10.1055/s-0031-1273427. Epub 2011 Jun 1.

PMID:
21638239
24.

Locomotor impairment and cerebrocortical oxidative stress in portal vein ligated rats in vivo.

Brück J, Görg B, Bidmon HJ, Zemtsova I, Qvartskhava N, Keitel V, Kircheis G, Häussinger D.

J Hepatol. 2011 Feb;54(2):251-7. doi: 10.1016/j.jhep.2010.06.035. Epub 2010 Sep 15.

PMID:
21084134
25.

Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy.

Görg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K, Häussinger D.

Hepatology. 2010 Jul;52(1):256-65. doi: 10.1002/hep.23656.

26.

Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy.

Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, Krause H, Pollok B, Gross J, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A.

Acta Neurol Scand. 2010 Jul;122(1):27-35. doi: 10.1111/j.1600-0404.2009.01246.x. Epub 2009 Dec 4.

PMID:
20003084
27.

Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy.

Miese FR, Wittsack HJ, Kircheis G, Holstein A, Mathys C, Mödder U, Cohnen M.

World J Gastroenterol. 2009 Nov 7;15(41):5157-64.

28.

Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation.

Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Häussinger D.

Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1383-94. doi: 10.1097/MEG.0b013e328310e0c3.

PMID:
19738480
29.

Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy.

Palomero-Gallagher N, Bidmon HJ, Cremer M, Schleicher A, Kircheis G, Reifenberger G, Kostopoulos G, Häussinger D, Zilles K.

Cell Physiol Biochem. 2009;24(3-4):291-306. doi: 10.1159/000233254. Epub 2009 Aug 3.

30.

Hepatic encephalopathy and fitness to drive.

Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, Häussinger D.

Gastroenterology. 2009 Nov;137(5):1706-15.e1-9. doi: 10.1053/j.gastro.2009.08.003. Epub 2009 Aug 15.

PMID:
19686744
31.

Quantitative cerebral water content mapping in hepatic encephalopathy.

Shah NJ, Neeb H, Kircheis G, Engels P, Häussinger D, Zilles K.

Neuroimage. 2008 Jul 1;41(3):706-17. doi: 10.1016/j.neuroimage.2008.02.057. Epub 2008 Mar 8.

PMID:
18456518
32.

Impaired cerebral oscillatory processing in hepatic encephalopathy.

Timmermann L, Butz M, Gross J, Ploner M, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A.

Clin Neurophysiol. 2008 Feb;119(2):265-72. Epub 2007 Dec 4.

PMID:
18055256
33.

Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis.

Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K, Bauer A.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):589-97. Epub 2007 Nov 14.

PMID:
18000666
34.

Assessment of low-grade hepatic encephalopathy: a critical analysis.

Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D.

J Hepatol. 2007 Nov;47(5):642-50. Epub 2007 Jul 23.

PMID:
17869373
35.

The treatment of hepatic encephalopathy.

Morgan MY, Blei A, Grüngreiff K, Jalan R, Kircheis G, Marchesini G, Riggio O, Weissenborn K.

Metab Brain Dis. 2007 Dec;22(3-4):389-405. Review.

PMID:
17846875
36.

1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.

Miese F, Kircheis G, Wittsack HJ, Wenserski F, Hemker J, Mödder U, Häussinger D, Cohnen M.

AJNR Am J Neuroradiol. 2006 May;27(5):1019-26.

37.

Neural synchronization in hepatic encephalopathy.

Timmermann L, Butz M, Gross J, Kircheis G, Häussinger D, Schnitzler A.

Metab Brain Dis. 2005 Dec;20(4):337-46. Review.

PMID:
16382344
38.

Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver.

Dransfeld O, Gehrmann T, Köhrer K, Kircheis G, Holneicher C, Häussinger D, Wettstein M.

Liver Int. 2005 Dec;25(6):1243-58.

PMID:
16343078
39.

Deficits in cortico-striatal synaptic plasticity and behavioral habituation in rats with portacaval anastomosis.

Sergeeva OA, Schulz D, Doreulee N, Ponomarenko AA, Selbach O, Borsch E, Kircheis G, Huston JP, Häussinger D, Haas HL.

Neuroscience. 2005;134(4):1091-8.

PMID:
16039790
40.

Pathological oscillatory coupling within the human motor system in different tremor syndromes as revealed by magnetoencephalography.

Timmermann L, Gross J, Butz M, Kircheis G, Haussinger D, Schnitzler A.

Neurol Clin Neurophysiol. 2004 Nov 30;2004:26.

PMID:
16012624
41.

Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study.

Zafiris O, Kircheis G, Rood HA, Boers F, Häussinger D, Zilles K.

Neuroimage. 2004 Jun;22(2):541-52.

PMID:
15193582
42.

[Hepatic encephalopathy--diagnostics].

Wettstein M, Kircheis G, Häussinger D.

Dtsch Med Wochenschr. 2003 Dec 12;128(50):2654-7. Review. German. No abstract available.

PMID:
14673742
43.

Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging.

Shah NJ, Neeb H, Zaitsev M, Steinhoff S, Kircheis G, Amunts K, Häussinger D, Zilles K.

Hepatology. 2003 Nov;38(5):1219-26.

PMID:
14578860
44.

Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling.

Timmermann L, Gross J, Butz M, Kircheis G, Häussinger D, Schnitzler A.

Neurology. 2003 Sep 9;61(5):689-92.

PMID:
12963765
45.

Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.

Kircheis G, Wettstein M, Dahl Sv, Häussinger D.

Metab Brain Dis. 2002 Dec;17(4):453-62. Review.

PMID:
12602521
46.

Management of hepatic encephalopathy.

Kircheis G, Häussinger D.

J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S260-7. Review.

PMID:
12472947
47.

Pathogenesis of hepatic encephalopathy.

Häussinger D, Schliess F, Kircheis G.

J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S256-9. Review.

PMID:
12472946
48.

Prevention of bile acid-induced apoptosis by betaine in rat liver.

Graf D, Kurz AK, Reinehr R, Fischer R, Kircheis G, Häussinger D.

Hepatology. 2002 Oct;36(4 Pt 1):829-39.

PMID:
12297830
49.

[Hepatic encephalopathy].

Häussinger D, Kircheis G.

Praxis (Bern 1994). 2002 May 29;91(22):957-63. Review. German.

PMID:
12094429
50.

Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D.

Hepatology. 2002 Feb;35(2):357-66.

PMID:
11826409

Supplemental Content

Loading ...
Support Center